ArticleJournal of medicinal chemistry2026
Correction to "From Discovery to Clinical Trial: YCT-529, an Oral NonHormonal Male Contraceptive Targeting the Retinoic Acid Receptor Alpha".
Rui Shi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.